Silver COT & Institutional Positioning — Smart Money Analysis
Silver institutional positioning: COT data, sentiment analysis and smart money flow assessment.
Silver institutional positioning: COT data, sentiment analysis and smart money flow assessment.
This week's Silver outlook: key drivers, volatility context, risk-opportunity assessment and the week ahead.
Silver key levels breakdown: support zones, resistance zones, confluence and price structure.
Extended
Mixed with near-term bearish technical bias—CoinCodex algorithm predicts -7.96% decline to $74.20 by March 21, analysts targeting $75-85 consolidation near-term with longer-term forecasts extending to $90-150 by mid-2026 if supply deficit persists, though FOMC outcome creates wide forecast dispersio
Extended
Most analysts targeting $80-95 consolidation near-term with longer-term forecasts extending to $100-150 by mid-2026 if supply deficit persists, though extreme volatility and Fed policy uncertainty create wide forecast dispersion
Extended
Most analysts targeting $85-100 consolidation near-term with longer-term forecasts extending to $100-150 by mid-2026 if supply deficit and China restrictions persist though CME intervention creates uncertainty and regulatory overhang
Most analysts maintain bullish silver outlook for 2026 targeting $90-120 on sixth deficit year and China supply restrictions, with JPMorgan as notable bear citing substitution risk
Most analysts targeting $75-85 consolidation near-term with longer-term forecasts extending to $90-150 by mid-2026 if supply deficit and China restrictions persist though CME intervention creates uncertainty and regulatory overhang capping near-term upside
Weekly Report
Most analysts targeting $75-90 consolidation near-term with longer-term forecasts extending to $100-150 by mid-2026 if supply deficit and China restrictions persist though CME intervention creates uncertainty and regulatory overhang
Weekly Report
Most analysts targeting $85-100 consolidation near-term with longer-term forecasts extending to $100-150 by mid-2026 if supply deficit and China restrictions persist though CME intervention creates uncertainty and regulatory overhang